Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,781 | -1,678 | -1,057 | -514 | -3,472 |
| Depreciation Amortization | 577 | 413 | 278 | 148 | 923 |
| Accounts receivable | -65 | N/A | N/A | N/A | 116 |
| Other Working Capital | -309 | 573 | 378 | 199 | 757 |
| Other Operating Activity | 834 | 259 | 181 | 5 | -58 |
| Operating Cash Flow | $-744 | $-433 | $-220 | $-162 | $-1,734 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -154 |
| Purchase Of Investment | 4 | 4 | 5 | 5 | -2 |
| Other Investing Activity | 35 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $39 | $4 | $5 | $5 | $-156 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26 | 6 | -44 | -34 | 72 |
| Common Stock Issued | 730 | 423 | 259 | 191 | 1,784 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -50 |
| Financing Cash Flow | $704 | $429 | $215 | $157 | $1,806 |
| Beginning Cash Position | 2 | 2 | 2 | 2 | 86 |
| End Cash Position | 1 | 2 | 2 | 2 | 2 |
| Net Cash Flow | $-1 | $N/A | $N/A | $N/A | $-84 |
| Free Cash Flow | |||||
| Operating Cash Flow | -744 | -433 | -220 | -162 | -1,734 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -154 |
| Free Cash Flow | -744 | -433 | -220 | -162 | -1,888 |